KAKerstin Amann

Kerstin Amann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kerstin Amann has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute syphilitic chorioretinitis after a missed primary diagnosis: a case report

    by Claudia Handtrack, Harald Knorr, Kerstin U Amann, Christoph Schoerner, Karl F Hilgers, Walter Geißdörfer

    Introduction: Syphilis is well known as an infectious disease which can present with a large variety of symptoms. Clinical diagnosis can be difficult and may be complicated in modern medicine by immunosuppressive treatment and possible side effects of medication. Case presentation: We describe a rare case of placoid chorioretinitis due to Treponema pallidum which developed after the primary symptom of proteinuria was not recognized as a rare manifestation of syphilis. Diagnosis of syphilitic chorioretinitis and/or endophthalmitis was made by broad range amplification of the bacterial 16S ribosomal RNA gene obtained from vitreous after diagnostic vitrectomy. Conclusion: This case shows that clinicians should be alert in patients with proteinuria and chorioretinitis as they can represent rare manifestations of syphilis. Syphilis should be in the differential diagnosis of any unknown symptom and in the presumed side effects of medication.


  • Die Bedeutung nicht traditioneller Risikofaktoren für Atherosklerose und Gefäßveränderungen bei chronischer Niereninsuffizienz

    by B. Karpe, K. Benz, V. Campean, D. Neureiter, F. Runck, C. Garlichs, B. Nonnast-Daniel, K. Hilgers, K. Amann


  • Diabetes mellitus

    by K. Amann, K. Benz


  • Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis

    by Christian S. Haas, Valentina Câmpean, Alexander Kuhlmann, Arno Dimmler, Udo Reulbach, Christian Forster, Thomas Aigner, Till Acker, Karl Plate, Kerstin Amann

    Capillary repair is crucial in the healing of glomerulonephritis (GN). The vascular endothelial growth factor (VEGF) has pro-angiogenic properties and plays an important role in glomerular capillary regeneration. Habu Snake Venom (HSV) GN, a murine model for mesangioproliferative GN, was induced in uninephrectomized C57/BL6 mice. Glomerular damage and capillary repair were assessed using morphometry, stereology, and confocal laser scanning microscopy. Mesangiolytic glomeruli were microdissected (days 1,3,7,14) using laser capture microdissection technique. VEGF mRNA expression was analyzed by real-time polymerase chain reaction and compared to intact glomeruli of healthy controls. Spatiotemporal VEGF gene and protein expression was determined using nonradioactive in situ hybridization and immunohistochemistry. On day 1, diseased animals developed focal mesangiolysis paralleled by a significant decrease in length density of glomerular capillaries that gradually returned to baseline levels thereafter, indicating capillary growth in response to initial injury. Glomerular VEGF mRNA expression increased on day 3 and returned back to baseline and beyond at day 14 when the glomerular recovery process was completed. Similarly, glomerular VEGF protein expression tended to be higher on day 3. The present study documents temporarily increased glomerular VEGF gene and protein expression during the healing of HSV GN, suggesting a potential role of VEGF in the repair of mesangiolytic glomerular damage.


  • Nonhypotensive dose of β-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure

    by Kerstin Amann, Jürgen Hofstetter, Valentina Câmpean, Andreas Koch, Marie-Luise Gross, Roland Veelken, Eberhard Ritz


  • Open Access

    Comprehensive immunohistological analysis of the endothelin system in human kidney grafts

    by Kathrin Frank, Martin Zeier, Marie-Luise Gross, Rüdiger Waldherr, Eberhard Ritz, Kerstin Amann

    Background. In experimental models of renal transplantation, upregulation of the endothelin (ET) system and amelioration of renal injury by ET-receptor blockers have been documented. In contrast, little information is available on the expression of the ET system in human kidney allografts. It was the purpose of the present study to analyse by immunohistology the expression of ET-1 as well as of the two ET receptors (ET-RA and ET-RB) in the different cells and compartments of kidney grafts and control kidneys. Methods. Fifty-five graft biopsies were taken from 55 kidney allograft recipients (mean age: 32±2.8 years) who were all on a calcineurin inhibitor. The indication for biopsies was delayed graft function or suspected rejection. The underlying diagnoses were acute allograft rejection ( n = 14), chronic allograft nephropathy ( n = 14), cyclosporin A (CSA) toxicity ( n = 10), post-operative acute tubular necrosis (ATN) ( n = 11) and recurrent primary disease ( n = 6). As control, tissues of non-grafted kidneys with ATN (mean age: 35±24 years), of primary glomerulonephritis (mean age: 69±10 years) and of non-tumour-bearing parts of eight tumour nephrectomy specimens (mean age: 67±5 years) were assessed. The biopsies were scored using the 1997 Banff criteria. Expression of ET-1, ET-RA and ET-RB as well as of vascular endothelial growth factor was evaluated by immunohistochemistry and a semi-quantitative scoring system. Interstitial infiltrating cells were characterized using antibodies against T cells, B cells and macrophages (CD3, CD20 and CD68). Results. Control cases showed only faint expression of ET-1 in glomeruli (in podocytes and endothelial cells), whereas marked expression was seen in distal, but less in proximal tubular cells. The interstitium was completely negative. ET-1 expression was seen in vascular endothelial cells (VEC) and vascular smooth muscle cells (VSMC). Only faint expression of ET-RA and ET-RB was found in glomeruli and tubuli (distal more than proximal). Marked ET-RA and ET-RB expression was seen in VEC and VSMC. In all transplanted kidneys, irrespective of the underlying diagnosis, expression of ET-1, ET-RA and ET-RB was markedly higher compared with control kidneys. ET-1 was strikingly upregulated in glomeruli and tubuli, but surprisingly not in the vasculature of grafts with CSA toxicity. Expression of ET-RB was markedly increased in CSA toxicity in glomeruli, tubuli and vessels. In grafts with ATN and acute rejection, pronounced expression of ET-RA was noted. There was a strong correlation between proteinuria and expression of ET-1 in glomeruli and proximal tubuli and of ET-RB in proximal tubuli. Conclusions. The above data in human kidney allograft biopsies are consistent with an important role of the ET system in different types of renal allograft damage. This finding extends and clarifies the somewhat contradictory results in animal models.


  • Open Access

    What you should know about the work-up of a renal biopsy

    by Kerstin Amann, Christian S. Haas

    To obtain relevant clinical information from a renal biopsy is an interdisciplinary task, requiring close cooperation between clinician and pathologist. The better the nephrologist's understanding, the more rewarding the information from the pathologist. Based on our experience, we will discuss some practical points which are not often known or are poorly handled by our clinical partners.


  • Open Access

    Impaired myocardial capillarogenesis and increased adaptive capillary growth in FGF2-deficient mice

    by Kerstin Amann, Jörg Faulhaber, Valentina Campean, Vitali Balajew, Rosanna Dono, Gerhard Mall, Heimo Ehmke


  • Low nephron number?a new cardiovascular risk factor in children?

    by Kerstin Amann, Christian Plank, Jörg Dötsch

    There is increasing evidence that primary hypertension, coronary heart disease, and other aspects of the so-called metabolic syndrome that develop in adulthood are primed in fetal life or early postnatally. The identification of this phenomenon, also known as prenatal or fetal programming, and the detailed characterization of the underlying pathomechanisms will greatly influence the understanding of these diseases. The present paper reviews recent experimental and clinical evidence that low nephron number, found in patients with renal dysplasia and low birth weight, is a risk factor for cardiovascular disease in later life. Therefore, it is important to identify children at risk as early as possible in order to treat them early and to prevent the development of end-organ damage. This could be an important goal for pediatrics in the near future.


  • Open Access

    Reply

    by Kerstin Amann

    The comment of Ivanovski et al. on the possible value of proteinuria in the evaluation of renal damage in ApoE knockout mice with and without renal failure is certainly important and deserves publication. One has to acknowledge, however, that morphological changes and proteinuria do not always go ‘hand-in-hand’. Moreover, proteinuria (or albuminuria) in mice is not that easy to measure and very often the variation between animals is extremely high. Furthermore, one has to acknowledge that the models used by Buzello et al. [1] and Bro et al. [2] are different from the model used by the authors.